Shandong Xinhua Pharmaceutical Company Limited - Asset Resilience Ratio

Latest as of December 2016: 0.64%

Shandong Xinhua Pharmaceutical Company Limited (XIN) has an Asset Resilience Ratio of 0.64% as of December 2016. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€30.00 Million

≈ $35.07 Million USD Cash + Short-term Investments

Total Assets

€4.72 Billion

≈ $5.52 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2016)

This chart shows how Shandong Xinhua Pharmaceutical Company Limited's Asset Resilience Ratio has changed over time. Check XIN PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Shandong Xinhua Pharmaceutical Company Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Shandong Xinhua Pharmaceutical Company L.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€30.00 Million	0.64%
Total Liquid Assets	€30.00 Million	0.64%

Asset Resilience Insights

Limited Liquidity: Shandong Xinhua Pharmaceutical Company Limited maintains only 0.64% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shandong Xinhua Pharmaceutical Company Limited Industry Peers by Asset Resilience Ratio

Compare Shandong Xinhua Pharmaceutical Company Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shanghai Haoyuan Chemexpress Co. Ltd. A SHG:688131	Drug Manufacturers - Specialty & Generic	1.37%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Celltrion Pharm Inc KQ:068760	Drug Manufacturers - Specialty & Generic	12.49%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Heilongjiang ZBD Pharmaceutical Co Ltd SHG:603567	Drug Manufacturers - Specialty & Generic	0.00%
Zhejiang Anglikang Pharmaceutical Co Ltd Class A SHE:002940	Drug Manufacturers - Specialty & Generic	9.11%

Annual Asset Resilience Ratio for Shandong Xinhua Pharmaceutical Company Limited (2016–2016)

The table below shows the annual Asset Resilience Ratio data for Shandong Xinhua Pharmaceutical Company Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2016-12-31	0.64%	€30.00 Million ≈ $35.07 Million	€4.72 Billion ≈ $5.52 Billion	--

pp = percentage points

About Shandong Xinhua Pharmaceutical Company Limited

F:XIN Germany Drug Manufacturers - Specialty & Generic

Market Cap

$161.86 Million

€138.45 Million EUR

Market Cap Rank

#17290 Global

#1637 in Germany

Share Price

€0.71

Change (1 day)

+8.40%

52-Week Range

€0.57 - €0.89

All Time High

€0.97